Inflammatory Eye Disease Week: A Call for Awareness and Action #United_States #Chicago #Uveitis #Prevent_Blindness #Keenova_Therapeutics
@newsen.bsky.social
@newsen.bsky.socialInflammatory Eye Disease Week: A Call for Awareness and Action #United_States #Chicago #Uveitis #Prevent_Blindness #Keenova_Therapeutics
@drnimaghadiri.bsky.socialBorrelia can invade the eye and trigger #uveitis.
A recognised pattern is intermediate uveitis with vitritis and retinal vasculitis. Lyme spirochaetes were first reported in human vitreous in 1985. This is uncommon, but potentially sight-threatening.
@drnimaghadiri.bsky.socialOn #WorldArthritisDay, we recognise the impact of arthritis on people’s lives
It can affect sight too 👁️ As a medical ophthalmologist, I work with rheumatology colleagues to treat #Uveitis/Ocular Inflammation and protect vision.
@drnimaghadiri.bsky.socialProud to have contributed to ASTUTE alongside many in the UK #uveitis community. This randomised trial supports wider access to adalimumab. Good empirical evidence must guide our treatment decisions & access to care.
Published in The Lancet portfolio here:
@journalneurooph.bsky.socialThe Association Between Uveitis and Optic Neuritis in Central Nervous System Demyelinating Disorders: A Multi-Institutional Cohort Study: JNO
Article link: bit.ly/JNO_ON_Uveitis
#brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Uveitis #MultipleSclerosis
@drnimaghadiri.bsky.socialColombia takes centre stage at the next IUSG Global Case Conference! 🇨🇴🌍
International collaboration is central to progress in ocular inflammation.
📅 Saturday 10 October 2026
🕐 13:00–15:00 UK | 14:00–16:00 CEST
💻 Online
@drnimaghadiri.bsky.socialA great start to the inaugural IUSG Case of the Month with 450 participants!
Red eyes, hearing loss and facial palsy led to granulomatosis with polyangiitis (GPA), a rare vasculitis.
Thanks to everyone who participated.
@drnimaghadiri.bsky.socialInternational consensus puts multimodal imaging at the heart of tubercular choroiditis care: ultrawide-field colour photography and OCT are cornerstones, with ICGA and OCTA revealing choroidal involvement beyond what is clinically visible.⬇️
@drnimaghadiri.bsky.socialLiverpool is on the TOFU map📍
We’re recruiting our third patient in Treatment Exit Options for Non-Infectious #Uveitis, an international registry asking when and how treatment can safely be reduced or stopped once inflammation is controlled.
International collaboration matters!
@drnimaghadiri.bsky.socialThe Multimodal Imaging in Uveitis (MUV) Taskforce has published Report 15: Evidence and Consensus-Based Imaging Guidelines in Cytomegalovirus Retinitis, now available in Ophthalmology Retina.
@drnimaghadiri.bsky.social🇮🇹 Join IUSG’s Global Case Conference 7: representative uveitis cases from Italy!
📅 Sat 12 Sept
🕐 13:00–14:30 BST | 14:00–15:30 CEST
Un’occasione per imparare insieme!
🔗 Register here: zoom.us/webinar/regi...
@drnimaghadiri.bsky.social🆕 Uveitis folks: try IUSG's new Case Challenge!
Test your clinical reasoning with our real-world MCQs, discuss with peers & get detailed explanations two weeks later.
No sign-up required: iusgcases.innovedha.com
